Back
Dynavax Technologies Vs. Deciphera Pharmaceuticals Industry Stock Comparison
Buy
66
DVAX
Dynavax Technologies
Last Price:
12.00
Seasonality Move:
13.02%
Buy
64
DCPH
Deciphera Pharmaceuticals
Last Price:
25.54
Seasonality Move:
19.08%
Buy
66
Dynavax Technologies (DVAX)
is a Buy
Is Dynavax Technologies a Buy, Sell or Hold?
- The current Dynavax Technologies [DVAX] share price is $11.99. The Score for DVAX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- DVAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Deciphera Pharmaceuticals (DCPH)
is a Buy
Is Deciphera Pharmaceuticals a Buy, Sell or Hold?
- The current Deciphera Pharmaceuticals [DCPH] share price is $25.54. The Score for DCPH is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DCPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DVAX Stock Price Chart
What is Dynavax Technologies's stock price today?
-
The Dynavax Technologies share price today is $11.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DVAX is experiencing slight buying pressure.
DCPH Stock Price Chart
What is Deciphera Pharmaceuticals's stock price today?
-
The Deciphera Pharmaceuticals share price today is $25.54
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DCPH is experiencing slight buying pressure.
DVAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 58.81 | Buy |
| Chaikin Money Flow: | 867580 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.11 - 11.77) | Buy |
| Bollinger Bands (100): | (11.49 - 13.19) | Sell |
DCPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 86.29 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.89 - 27.11) | Buy |
| Bollinger Bands (100): | (13.28 - 22.1) | Buy |
DVAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.68 | Buy |
| 20-day SMA: | 11.44 | Buy |
| 50-day SMA: | 11.71 | Buy |
| 200-day SMA: | 13.18 | Sell |
| 8-day EMA: | 11.66 | Buy |
| 20-day EMA: | 11.55 | Buy |
| 50-day EMA: | 11.75 | Buy |
| 200-day EMA: | 12.55 | Sell |
DCPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.51 | Buy |
| 20-day SMA: | 25.45 | Buy |
| 50-day SMA: | 20.03 | Buy |
| 200-day SMA: | 15.48 | Buy |
| 8-day EMA: | 25.48 | Buy |
| 20-day EMA: | 24.51 | Buy |
| 50-day EMA: | 21.51 | Buy |
| 200-day EMA: | 16.96 | Buy |
Dynavax Technologies Earnings Growth & DVAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.10 per share, an increase this year of $0.39 per share, and an increase next year of $0.39 per share.
Deciphera Pharmaceuticals Earnings Growth & DCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.01 per share, an increase this year of $0.24 per share, and an increase next year of $0.41 per share.
Dynavax Technologies Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Deciphera Pharmaceuticals Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||